Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Cash from Investing Activities (2018 - 2024)

Dna X (SONM) has disclosed Cash from Investing Activities for 7 consecutive years, with -$8000.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Cash from Investing Activities rose 33.33% year-over-year to -$8000.0, compared with a TTM value of -$214000.0 through Dec 2024, down 1326.67%, and an annual FY2024 reading of -$214000.0, down 494.44% over the prior year.
  • Cash from Investing Activities was -$8000.0 for Q4 2024 at Dna X, up from -$137000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $192000.0 in Q4 2020 and bottomed at -$184000.0 in Q1 2020.
  • Average Cash from Investing Activities over 5 years is -$19428.6, with a median of -$9500.0 recorded in 2020.
  • The sharpest move saw Cash from Investing Activities skyrocketed 290.1% in 2020, then tumbled 13600.0% in 2024.
  • Year by year, Cash from Investing Activities stood at $192000.0 in 2020, then crashed by 113.54% to -$26000.0 in 2021, then surged by 92.31% to -$2000.0 in 2022, then crashed by 500.0% to -$12000.0 in 2023, then soared by 33.33% to -$8000.0 in 2024.
  • Business Quant data shows Cash from Investing Activities for SONM at -$8000.0 in Q4 2024, -$137000.0 in Q3 2024, and -$39000.0 in Q2 2024.